266 related articles for article (PubMed ID: 29325452)
1. Inherited Cancer in the Age of Next-Generation Sequencing.
Price KS; Svenson A; King E; Ready K; Lazarin GA
Biol Res Nurs; 2018 Mar; 20(2):192-204. PubMed ID: 29325452
[TBL] [Abstract][Full Text] [Related]
2. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
4. Application of Panel-Based Tests for Inherited Risk of Cancer.
Shah PD; Nathanson KL
Annu Rev Genomics Hum Genet; 2017 Aug; 18():201-227. PubMed ID: 28504904
[TBL] [Abstract][Full Text] [Related]
5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
6. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR
Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627
[TBL] [Abstract][Full Text] [Related]
7. Multigene Panel Testing for Hereditary Cancer and Genetic Counseling.
Lee ES; Kim J; Han W
Adv Exp Med Biol; 2021; 1187():455-471. PubMed ID: 33983594
[TBL] [Abstract][Full Text] [Related]
8. Cancer genomics and inherited risk.
Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genetic testing approach for major inherited kidney diseases, using next-generation sequencing with a custom panel.
Mori T; Hosomichi K; Chiga M; Mandai S; Nakaoka H; Sohara E; Okado T; Rai T; Sasaki S; Inoue I; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):63-75. PubMed ID: 26920127
[TBL] [Abstract][Full Text] [Related]
10. Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test.
Shin HC; Lee HB; Yoo TK; Lee ES; Kim RN; Park B; Yoon KA; Park C; Lee ES; Moon HG; Noh DY; Kong SY; Han W
Cancer Res Treat; 2020 Jul; 52(3):697-713. PubMed ID: 32019277
[TBL] [Abstract][Full Text] [Related]
11. Targeted next-generation sequencing as a diagnostic tool in gastrointestinal system cancer/polyposis patients.
Yalcintepe S; Gurkan H; Demir S; Tozkir H; Tezel HA; Atli EI; Atli E; Eker D; Cicin I
Tumori; 2020 Dec; 106(6):510-517. PubMed ID: 32390558
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of laboratory perspectives on hereditary cancer panels.
Stoll J; Weissman SM; Hook N; Selkirk C; Johnson AK; Newlin A; Vogel Postula KJ
Fam Cancer; 2016 Oct; 15(4):689-96. PubMed ID: 26869169
[TBL] [Abstract][Full Text] [Related]
13. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
[TBL] [Abstract][Full Text] [Related]
14. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
15. Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.
Cragun D; Kinney AY; Pal T
Expert Rev Mol Diagn; 2017 Jan; 17(1):57-70. PubMed ID: 27910721
[TBL] [Abstract][Full Text] [Related]
16. Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.
Hamilton JG; Robson ME
Hastings Cent Rep; 2019 May; 49 Suppl 1(Suppl 1):S44-S52. PubMed ID: 31268573
[TBL] [Abstract][Full Text] [Related]
17. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel.
Coffee B; Cox HC; Kidd J; Sizemore S; Brown K; Manley S; Mancini-DiNardo D
Cancer Genet; 2017 Feb; 211():5-8. PubMed ID: 28279308
[TBL] [Abstract][Full Text] [Related]
18. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
[TBL] [Abstract][Full Text] [Related]
19. Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice.
Selkirk CG; Vogel KJ; Newlin AC; Weissman SM; Weiss SM; Wang CH; Hulick PJ
Fam Cancer; 2014 Dec; 13(4):527-36. PubMed ID: 25117502
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]